A detailed history of Advisor Group Holdings, Inc. transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,259 shares of NMTC stock, worth $818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,259
Previous 1,259 -0.0%
Holding current value
$818
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.68 - $1.27 $618 - $1,154
909 Added 259.71%
1,259 $1,000
Q4 2023

Feb 12, 2024

SELL
$0.86 - $1.92 $301 - $672
-350 Reduced 50.0%
350 $0
Q3 2023

Nov 13, 2023

BUY
$0.85 - $1.99 $297 - $696
350 Added 100.0%
700 $0
Q4 2022

Feb 10, 2023

BUY
$0.84 - $2.82 $294 - $987
350 New
350 $0

Others Institutions Holding NMTC

About NEUROONE MEDICAL TECHNOLOGIES Corp


  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $10.5M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.